secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001826667-25-000018
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.03, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus draws $10M under senior secured credit facility; issues warrants for 91,263 shares
--------------------------------------------------------------------------------

- Closed Second Tranche of $50M credit facility, receiving $10M on Feb 18, 2025.
- Loan maturity date is April 30, 2029.
- Issued warrants to OrbiMed to purchase 91,263 shares at $5.4787 per share.
- Warrants have a 7-year term and contain customary share/price adjustment provisions.
- Third Tranche of up to $15M remains available until Dec 31, 2025 subject to revenue conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000018/0001826667-25-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000018/tlsi-20250218.htm
  HTML page:      https://secwatch.observer/filing/0001826667-25-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer